Purpose - To review conceptual issues regarding confounding by indication i
n the context of studies of calcium channel blockers (CCBs).
Methods - Review of literature, with special attention to two articles in t
he current issue.
Results - Conflicting arguments about the presence of uncontrollable confou
nding by indication in studies of CCBs are reviewed and criticized. Studies
with potential confounding by indication can benefit from appropriate anal
ytic methods, including separating the effects of a drug taken at different
times, sensitivity analysis for unmeasured confounders, and instrumental v
ariables and G-estimation.
Conclusions - Whether confounding by indication accounts for observed assoc
iations is often difficult to determine; this is the case in studies of CCB
s. When confounding by indication is suspected, a variety of methods to dea
l with it may be useful. Copyright (C) 2000 John Wiley & Sons, Ltd.